Tuesday 15 July 2014 13:30 – 15:00
Track 4 - DNA repair & Topoisomerase Inhibitors in Oncology
Chair: Beverly Teicher
Drugging Topoisomerases: Lessons and Challenges
Yves Pommier
PARP and CHK inhibitors as anticancer therapeutics
To be advised
DNA topoisomerase I: New insights into cancer therapy
Mary-Ann Bjornsti